Registering for more than one person? A TMA login is required for each person you register. Need help? Contact the TMA Knowledge Center at (800) 880-7955.
You must select a location to proceed.
Yes
No
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
This program is eligible to count towards federal and/or state mandated trainings.*
The passage of new Centers for Disease Control and Prevention (CDC) guidelines has come and gone, but how much have our practices changed and how much has this impacted patients with chronic pain?
In this lecture, we will dive into the changes from 2016 to 2022 in the CDC guidelines for opioid management. We will review the impact these changes have brought in the past year with the current opioid epidemic and how this has affected overall chronic pain management across specialties. This is a lecture for all specialties that interact with chronic pain patients and will aim to provide insight into solutions for the future.
Best Bits
Opioid by the numbers
2022 CDC guidelines
The clinical approach
Learning Objectives Upon completion, the participant should be able to:
Discuss the changes in recommendations between the 2016 and the 2022 CDC guidelines for prescribing opioids;
Assess the impacts in how we practice and approach opioid management; and
Using case scenarios, critique decision-making around opioid management.
Competencies This program is designed to address Practice-based Learning and Improvement; Professionalism; and Systems-based Practice ACGME/ABMS competency.
*Meeting Mandated CME Requirements This program is eligible to count towards: (i) the eight hours of training on treatment and management of patients with opioid or other substance use disorders required for all U.S. Drug Enforcement Administration-registered practitioners, and (ii) the two hours of CME in the study of pain management and the prescribing and monitoring of controlled substances required by the Texas Medical Board.
This program will address the TMB specified topics of:
Best practices, alternative treatment options, and multimodal approaches to pain management that may include physical therapy, psychotherapy, and other treatments;
Safe and effective pain management related to the prescription of opioids and other controlled substances, including education regarding:
Standards of care;
Identification of drug-seeking behavior in patients; and
Effectively communicating with patients about the prescription of an opioid or other controlled substances, and
prescribing and monitoring of controlled substances.
Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
Recorded: May 4, 2024 Released: June 1, 2024 Expires: June1, 2027
Return Policy No refunds or exchanges will be processed for this program.
0.75 AMA PRA Category 1 Credits™ (Enduring) The Texas Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Medical Association designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
On select courses, the Texas Medical Association requires physician to complete 70-percent of the test questions correctly to receive credit for this course.
0.75 ETHICS This course has been designated for 0.75 credit(s) of education in medical ethics and/or professional responsibility.
0.75 Opioid This program is eligible to count towards the two hours of CME in the study of pain management and the prescribing and monitoring of controlled substances required by the Texas Medical Board. See the program description for the specific topics identified by the TMB that this program addresses. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
0.75 DEA SUD The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. This program is eligible to count towards the training requirement. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.
Customers Who Bought This Item Also Bought
(Online Course) Patient Safety and Medical Errors
(PDF) Stress Relieving Breathing Techniques
(On Demand Webinar) ChatGPT and AI: Ways to Integrate Into Patient Care
(CME to Go/Podcast) Annual Checkup: Is Your Career on Track?
(CME to Go/Podcast) Building Relationships to Support Physician Well-Being
(On Demand Webinar) AI in Health Care: Can it Deter Physician Burnout?
(On Demand Webinar) 2025 Medicare Physician Fee Schedule
(On Demand Webinar) HIPAA Training for Medical Office Staff
(PDF) Identifying Human Trafficking in Texas: What Physicians Need to Know
(On Demand Webinar) Complying With HIPAA Security Rule and Texas Data Security Laws
(PDF) Enhancing Communication to Improve Patient Safety and Professional Satisfaction
(PDF) Texas Medical Board Investigations: A Physician’s Guide Through the Disciplinary Process
Adding Registration, Please wait...
